Diabetic patients taking GLP-1s may face increased risk of eye disease, study suggests
Diabetes is the leading cause of vision loss in people between 18 and 64 years old, according to the American Diabetes Association — and the best way to prevent this is to control blood sugar levels.
Glucagon-like peptide-1 receptor agonists (GLP-1s), such as Ozempic and Mounjaro, have become popular medications for controlling diabetes and treating obesity — but new Canadian research suggests they can also lead to a paradoxical side effect in the form of eye problems.
YOUNG POLICE OFFICER DIES BY SUICIDE AFTER 'DEBILITATING' LASER EYE SURGERY COMPLICATIONS
A retrospective study conducted from January 2020 to November 2023 included more than 139,000 diabetic patients, some of whom were taking GLP-1s for at least six months and some who were not taking the medications over a three-year period.
The average age of the participants was 66 years old, and approximately 47% were women.
Researchers found that the participants taking the weight-loss medications had twice the risk of d..